Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Altered microRNA processing proteins in HPV-induced cancers.

Snoek BC, Babion I, Koppers-Lalic D, Pegtel DM, Steenbergen RD.

Curr Opin Virol. 2019 Aug 10;39:23-32. doi: 10.1016/j.coviro.2019.07.002. [Epub ahead of print] Review.

2.

FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.

Vink FJ, Meijer CJLM, Clifford GM, Poljak M, Oštrbenk A, Petry KU, Rothe B, Bonde J, Pedersen H, de Sanjosé S, Torres M, Del Pino M, Quint WGV, Cuschieri K, Boada EA, van Trommel NE, Lissenberg-Witte BI, Floore AN, Hesselink AT, Steenbergen RDM, Bleeker MCG, Heideman DAM.

Int J Cancer. 2019 Aug 7. doi: 10.1002/ijc.32614. [Epub ahead of print]

PMID:
31390052
3.

The use of molecular markers for cervical screening of women living with HIV in South Africa.

Kremer WW, van Zummeren M, Breytenbach E, Richter KL, Steenbergen RDM, Meijer CJLM, Dreyer G.

AIDS. 2019 Nov 1;33(13):2035-2042. doi: 10.1097/QAD.0000000000002325.

PMID:
31385866
4.

Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.

Dick S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, Steenbergen RDM, Meijer CJLM, Berkhof J, Heideman DAM.

Gynecol Oncol. 2019 Aug;154(2):368-373. doi: 10.1016/j.ygyno.2019.06.002. Epub 2019 Jun 8.

PMID:
31182225
5.

HPV16 variant analysis in primary and recurrent CIN2/3 lesions demonstrates presence of the same consensus variant.

van der Weele P, King AJ, Meijer CJLM, Steenbergen RDM.

Papillomavirus Res. 2019 Jun;7:168-172. doi: 10.1016/j.pvr.2019.04.008. Epub 2019 Apr 13.

6.

Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.

Babion I, De Strooper LMA, Luttmer R, Bleeker MCG, Meijer CJLM, Heideman DAM, Wilting SM, Steenbergen RDM.

Epigenetics. 2019 Jun;14(6):558-567. doi: 10.1080/15592294.2019.1600390. Epub 2019 Apr 8.

7.

Cervical cancer detection by DNA methylation analysis in urine.

Snoek BC, Splunter APV, Bleeker MCG, Ruiten MCV, Heideman DAM, Rurup WF, Verlaat W, Schotman H, Gent MV, Trommel NEV, Steenbergen RDM.

Sci Rep. 2019 Feb 28;9(1):3088. doi: 10.1038/s41598-019-39275-2.

8.

A two-gene methylation signature for the diagnosis of bladder cancer in urine.

Bosschieter J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, Segerink LI, Vis AN, Wilting SM, Lissenberg-Witte BI, A van Moorselaar RJ, Steenbergen RD.

Epigenomics. 2019 Feb;11(3):337-347. doi: 10.2217/epi-2018-0094. Epub 2019 Feb 1.

PMID:
30706728
9.

HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.

Kremer WW, van Zummeren M, Heideman DAM, Lissenberg-Witte BI, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM.

Int J Mol Sci. 2018 Oct 23;19(11). pii: E3297. doi: 10.3390/ijms19113297.

10.

Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.

Snoek BC, Verlaat W, Babion I, Novianti PW, van de Wiel MA, Wilting SM, van Trommel NE, Bleeker MCG, Massuger LFAG, Melchers WJG, Sie D, Heideman DAM, Snijders PJF, Meijer CJLM, Steenbergen RDM.

Int J Cancer. 2019 Jan 15;144(2):372-379. doi: 10.1002/ijc.31855. Epub 2018 Nov 4.

11.

A protocol for urine collection and storage prior to DNA methylation analysis.

Bosschieter J, Bach S, Bijnsdorp IV, Segerink LI, Rurup WF, van Splunter AP, Bahce I, Novianti PW, Kazemier G, van Moorselaar RJA, Steenbergen RDM, Nieuwenhuijzen JA.

PLoS One. 2018 Aug 24;13(8):e0200906. doi: 10.1371/journal.pone.0200906. eCollection 2018.

12.

HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.

Zummeren MV, Kremer WW, Leeman A, Bleeker MCG, Jenkins D, Sandt MV, Doorbar J, Heideman DAM, Steenbergen RDM, Snijders PJF, Kenter GG, Quint WGV, Berkhof J, Meijer CJLM.

Mod Pathol. 2018 Dec;31(12):1842-1850. doi: 10.1038/s41379-018-0101-z. Epub 2018 Aug 22.

PMID:
30135508
13.

Detection of hypermethylated genes as markers for cervical screening in women living with HIV.

Kremer WW, Van Zummeren M, Novianti PW, Richter KL, Verlaat W, Snijders PJ, Heideman DA, Steenbergen RD, Dreyer G, Meijer CJ.

J Int AIDS Soc. 2018 Aug;21(8):e25165. doi: 10.1002/jia2.25165.

14.

Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.

Verlaat W, Van Leeuwen RW, Novianti PW, Schuuring E, Meijer CJLM, Van Der Zee AGJ, Snijders PJF, Heideman DAM, Steenbergen RDM, Wisman GBA.

Epigenetics. 2018;13(7):769-778. doi: 10.1080/15592294.2018.1507197. Epub 2018 Aug 24.

15.

Host Cell Deoxyribonucleic Acid Methylation Markers for the Detection of High-grade Anal Intraepithelial Neoplasia and Anal Cancer.

van der Zee RP, Richel O, van Noesel CJM, Novianti PW, Ciocanea-Teodorescu I, van Splunter AP, Duin S, van den Berk GEL, Meijer CJLM, Quint WGV, de Vries HJC, Prins JM, Steenbergen RDM.

Clin Infect Dis. 2019 Mar 19;68(7):1110-1117. doi: 10.1093/cid/ciy601.

16.

Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.

Swarts DRA, Voorham QJM, van Splunter AP, Wilting SM, Sie D, Pronk D, van Beurden M, Heideman DAM, Snijders PJF, Meijer CJLM, Steenbergen RDM, Bleeker MCG.

Cancer Med. 2018 Sep;7(9):4542-4553. doi: 10.1002/cam4.1633. Epub 2018 Jul 20.

17.

Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.

Babion I, Snoek BC, Novianti PW, Jaspers A, van Trommel N, Heideman DAM, Meijer CJLM, Snijders PJF, Steenbergen RDM, Wilting SM.

Clin Epigenetics. 2018 Jun 7;10:76. doi: 10.1186/s13148-018-0509-9. eCollection 2018.

18.

The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review.

Bosschieter J, Lutz C, Segerink LI, Vis AN, Zwarthoff EC, A van Moorselaar RJ, van Rhijn BW, Heymans MW, Jansma EP, Steenbergen RD, Nieuwenhuijzen JA.

Epigenomics. 2018 May;10(5):673-687. doi: 10.2217/epi-2017-0156. Epub 2018 Apr 25.

PMID:
29692199
19.

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.

De Strooper LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, Snijders PJF, Meijer CJLM, Heideman DAM.

Int J Cancer. 2018 Sep 15;143(6):1541-1548. doi: 10.1002/ijc.31539. Epub 2018 Apr 27.

20.

Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.

Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, van Splunter AP, Peeters CFW, van Trommel NE, Massuger LFAG, Bekkers RLM, Melchers WJG, van Kemenade FJ, Berkhof J, van de Wiel MA, Meijer CJLM, Steenbergen RDM.

Clin Cancer Res. 2018 Jul 15;24(14):3456-3464. doi: 10.1158/1078-0432.CCR-17-3615. Epub 2018 Apr 9.

21.

The effect of ART on cervical cancer precursor lesions.

de Vries HJC, Steenbergen RDM.

Lancet HIV. 2018 Jan;5(1):e6-e8. doi: 10.1016/S2352-3018(17)30189-3. Epub 2017 Oct 26. No abstract available.

22.

Molecular events leading to HPV-induced high grade neoplasia.

Wilting SM, Steenbergen RDM.

Papillomavirus Res. 2016 Dec;2:85-88. doi: 10.1016/j.pvr.2016.04.003. Epub 2016 Apr 12. Review.

23.

A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens.

Babion I, Snoek BC, van de Wiel MA, Wilting SM, Steenbergen RDM.

J Mol Diagn. 2017 Sep;19(5):625-637. doi: 10.1016/j.jmoldx.2017.04.010.

PMID:
28826607
24.

Selection of women at risk for cervical cancer in an HIV-infected South African population.

Van Zummeren M, Kremer WW, Van Aardt MC, Breytenbach E, Richter KL, Rozendaal L, Witte BI, De Strooper LMA, Hesselink AT, Heideman DAM, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM.

AIDS. 2017 Sep 10;31(14):1945-1953. doi: 10.1097/QAD.0000000000001583.

PMID:
28692545
25.

Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequences.

Meijer CJLM, Steenbergen RDM.

Nat Rev Clin Oncol. 2017 Jul;14(7):397-398. doi: 10.1038/nrclinonc.2017.52. Epub 2017 Apr 11. No abstract available.

PMID:
28397825
26.

Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.

Khan S, Oosterhuis K, Wunderlich K, Bunnik EM, Bhaggoe M, Boedhoe S, Karia S, Steenbergen RDM, Bosch L, Serroyen J, Janssen S, Schuitemaker H, Vellinga J, Scheper G, Zahn R, Custers J.

Int J Cancer. 2017 Jul 15;141(2):393-404. doi: 10.1002/ijc.30679. Epub 2017 Apr 24.

27.

Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.

Verlaat W, Snijders PJF, Novianti PW, Wilting SM, De Strooper LMA, Trooskens G, Vandersmissen J, Van Criekinge W, Wisman GBA, Meijer CJLM, Heideman DAM, Steenbergen RDM.

Clin Cancer Res. 2017 Jul 15;23(14):3813-3822. doi: 10.1158/1078-0432.CCR-16-2641. Epub 2017 Jan 24.

28.

High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7.

Aromseree S, Middeldorp JM, Pientong C, van Eijndhoven M, Ramayanti O, Lougheed SM, Pegtel DM, Steenbergen RD, Ekalaksananan T.

PLoS One. 2017 Jan 5;12(1):e0169290. doi: 10.1371/journal.pone.0169290. eCollection 2017.

29.

Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer.

Molano M, Moreno-Acosta P, Morales N, Burgos M, Buitrago L, Gamboa O, Alvarez R, Garland SM, Tabrizi SN, Steenbergen RD, Mejía JC.

Cancer Genomics Proteomics. 2016 11-12;13(6):483-491.

30.

Immortalization capacity of HPV types is inversely related to chromosomal instability.

Schütze DM, Krijgsman O, Snijders PJ, Ylstra B, Weischenfeldt J, Mardin BR, Stütz AM, Korbel JO, de Winter JP, Meijer CJ, Quint WG, Bosch L, Wilting SM, Steenbergen RD.

Oncotarget. 2016 Jun 21;7(25):37608-37621. doi: 10.18632/oncotarget.8058.

31.

Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.

Wang R, van Leeuwen RW, Boers A, Klip HG, de Meyer T, Steenbergen RD, van Criekinge W, van der Zee AG, Schuuring E, Wisman GB.

Oncotarget. 2016 Dec 6;7(49):80735-80750. doi: 10.18632/oncotarget.12598.

32.

Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.

Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ.

Int J Cancer. 2017 Jan 15;140(2):423-430. doi: 10.1002/ijc.30449. Epub 2016 Oct 11.

33.

Somatic mutation in PIK3CA is a late event in cervical carcinogenesis.

Verlaat W, Snijders PJ, van Moorsel MI, Bleeker M, Rozendaal L, Sie D, Ylstra B, Meijer CJ, Steenbergen RD, Heideman DA.

J Pathol Clin Res. 2015 Sep 21;1(4):207-11. doi: 10.1002/cjp2.27. eCollection 2015 Oct.

34.

DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.

Hubers AJ, Heideman DA, Duin S, Witte BI, de Koning HJ, Groen HJ, Prinsen CF, Bolijn AS, Wouters M, van der Meer SE, Steenbergen RD, Snijders PJ, Uyterlinde A, Berkhof H, Smit EF, Thunnissen E.

J Clin Pathol. 2017 Mar;70(3):250-254. doi: 10.1136/jclinpath-2016-203734. Epub 2016 Aug 5.

PMID:
27496969
35.

Management of high-risk HPV-positive women for detection of cervical (pre)cancer.

Luttmer R, De Strooper LM, Steenbergen RD, Berkhof J, Snijders PJ, Heideman DA, Meijer CJ.

Expert Rev Mol Diagn. 2016 Sep;16(9):961-74. doi: 10.1080/14737159.2016.1217157. Epub 2016 Aug 5. Review.

PMID:
27459506
36.

Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.

Uijterwaal MH, van Zummeren M, Kocken M, Luttmer R, Berkhof J, Witte BI, van Baal WM, Graziosi GCM, Verheijen RHM, Helmerhorst TJM, van Dijken DKE, Spruijt JWM, van Kemenade FJ, Fransen-Daalmeijer N, Bekker-Lettink M, Heideman DAM, Snijders PJF, Steenbergen RDM, Meijer CJLM.

Gynecol Oncol. 2016 Oct;143(1):135-142. doi: 10.1016/j.ygyno.2016.07.089. Epub 2016 Jul 16.

PMID:
27430395
37.

Prevalence of Neovaginal High-Risk Human Papillomavirus Among Transgender Women in The Netherlands.

van der Sluis WB, Buncamper ME, Bouman MB, Elfering L, Özer M, Bogaarts M, Steenbergen RD, Heideman DA, Mullender MG.

Sex Transm Dis. 2016 Aug;43(8):503-5. doi: 10.1097/OLQ.0000000000000476.

PMID:
27414682
38.

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.

Luttmer R, De Strooper LM, Dijkstra MG, Berkhof J, Snijders PJ, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, van Baal WM, Graziosi PG, Quint WG, Spruijt JW, van Dijken DK, Heideman DA, Meijer CJ.

Br J Cancer. 2016 Aug 23;115(5):579-87. doi: 10.1038/bjc.2016.200. Epub 2016 Jul 14.

39.

Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.

Wilting SM, Miok V, Jaspers A, Boon D, Sørgård H, Lando M, Snoek BC, van Wieringen WN, Meijer CJ, Lyng H, Snijders PJ, Steenbergen RD.

Oncotarget. 2016 Jul 12;7(28):43805-43819. doi: 10.18632/oncotarget.9698.

40.

Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature.

van der Sluis WB, Buncamper ME, Bouman MB, Neefjes-Borst EA, Heideman DAM, Steenbergen RDM, Mullender MG.

Sex Transm Infect. 2016 Nov;92(7):499-501. doi: 10.1136/sextrans-2015-052456. Epub 2016 Mar 24.

PMID:
27013740
41.

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.

De Strooper LMA, Verhoef VMJ, Berkhof J, Hesselink AT, de Bruin HME, van Kemenade FJ, Bosgraaf RP, Bekkers RLM, Massuger LFAG, Melchers WJG, Steenbergen RDM, Snijders PJF, Meijer CJLM, Heideman DAM.

Gynecol Oncol. 2016 May;141(2):341-347. doi: 10.1016/j.ygyno.2016.02.012. Epub 2016 Mar 3.

42.

Disc large 1 expression is altered by human papillomavirus E6/E7 proteins in organotypic cultures of human keratinocytes.

Valdano MB, Cavatorta AL, Morale MG, Marziali F, de Souza Lino V, Steenbergen RD, Boccardo E, Gardiol D.

J Gen Virol. 2016 Feb;97(2):453-62. doi: 10.1099/jgv.0.000364. Epub 2015 Dec 9.

PMID:
26653181
43.

Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).

Luttmer R, De Strooper LM, Berkhof J, Snijders PJ, Dijkstra MG, Uijterwaal MH, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, Van Baal WM, Graziosi PG, Quint WG, Heideman DA, Meijer CJ.

Int J Cancer. 2016 Feb 15;138(4):992-1002. doi: 10.1002/ijc.29824. Epub 2015 Sep 14.

44.

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.

Lando M, Fjeldbo CS, Wilting SM, C Snoek B, Aarnes EK, Forsberg MF, Kristensen GB, Steenbergen RD, Lyng H.

Epigenetics. 2015;10(10):970-80. doi: 10.1080/15592294.2015.1085140.

45.

Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.

de Groen FL, Timmer LM, Menezes RX, Diosdado B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B.

PLoS One. 2015 Jul 6;10(7):e0132495. doi: 10.1371/journal.pone.0132495. eCollection 2015.

46.

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.

Hubers AJ, Heideman DA, Burgers SA, Herder GJ, Sterk PJ, Rhodius RJ, Smit HJ, Krouwels F, Welling A, Witte BI, Duin S, Koning R, Comans EF, Steenbergen RD, Postmus PE, Meijer GA, Snijders PJ, Smit EF, Thunnissen E.

Br J Cancer. 2015 Mar 17;112(6):1105-13. doi: 10.1038/bjc.2014.636.

47.

Mining for viral fragments in methylation enriched sequencing data.

Mensaert K, Van Criekinge W, Thas O, Schuuring E, Steenbergen RD, Wisman GB, De Meyer T.

Front Genet. 2015 Feb 4;6:16. doi: 10.3389/fgene.2015.00016. eCollection 2015.

48.

Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.

Verhoef VM, van Kemenade FJ, Rozendaal L, Heideman DA, Bosgraaf RP, Hesselink AT, Melchers WJ, Massuger LF, Bekkers RL, Steenbergen RD, Berkhof J, Snijders PJ, Meijer CJ.

Gynecol Oncol. 2015 Apr;137(1):55-9. doi: 10.1016/j.ygyno.2015.01.550. Epub 2015 Feb 8.

PMID:
25667975
49.

Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.

Schütze DM, Kooter JM, Wilting SM, Meijer CJ, Quint W, Snijders PJ, Steenbergen RD.

Epigenetics. 2015;10(1):73-81. doi: 10.4161/15592294.2014.990787. Epub 2015 Jan 23.

50.

Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.

Pinheiro C, Garcia EA, Morais-Santos F, Scapulatempo-Neto C, Mafra A, Steenbergen RD, Boccardo E, Villa LL, Baltazar F, Longatto-Filho A.

BMC Cancer. 2014 Oct 8;14:751. doi: 10.1186/1471-2407-14-751.

Supplemental Content

Loading ...
Support Center